<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32352894</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8976</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>7</Issue><PubDate><Year>2020</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Viral immunology</Title><ISOAbbreviation>Viral Immunol</ISOAbbreviation></Journal><ArticleTitle>Coxsackievirus B4 Exposure Results in Variable Pattern Recognition Response in the Kidneys of Female Non-Obese Diabetic Mice Before Establishment of Diabetes.</ArticleTitle><Pagination><StartPage>494</StartPage><EndPage>506</EndPage><MedlinePgn>494-506</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1089/vim.2019.0188</ELocationID><Abstract><AbstractText>End-stage renal disease (ESRD) is described by four primary diagnoses, diabetes, hypertension, glomerulonephritis, and cystic kidney disease, all of which have viruses implicated as causative agents. Enteroviruses, such as coxsackievirus (CV), are a common genus of viruses that have been implicated in both diabetes and cystic kidney disease; however, little is known about how CVs cause kidney injury and ESRD or predispose individuals with a genetic susceptibility to type 1 diabetes (T1D) to kidney injury. This study evaluated kidney injury resulting from coxsackievirus B4 (CVB4) inoculation of non-obese diabetic (NOD) mice to glean a better understanding of how viral exposure may predispose individuals with a genetic susceptibility to T1D to kidney injury. The objectives were to assess acute and chronic kidney damage in CVB4-inoculated NOD mice without diabetes. Results indicated the presence of CVB4 RNA in the kidney for at least 14 days post-CVB4 inoculation and a coordinated pattern recognition receptor response, but the absence of an immune response or cytotoxicity. CVB4-inoculated NOD mice also had a higher propensity to develop an increase in mesangial area 17 weeks post-CVB4 inoculation. These studies identified initial gene expression changes in the kidney resulting from CVB4 exposure that may predispose to ESRD. Thus, this study provides an initial characterization of kidney injury resulting from CVB4 inoculation of mice that are genetically susceptible to developing T1D that may one day provide better therapeutic options and predictive measures for patients who are at risk for developing kidney disease from T1D.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Walter</LastName><ForeName>Debra L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Interdisciplinary Program in Molecular and Cellular Biology, Ohio University, Athens, Ohio, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Sciences, College of Arts and Sciences, Ohio University, Athens, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benner</LastName><ForeName>Sarah E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Interdisciplinary Program in Molecular and Cellular Biology, Ohio University, Athens, Ohio, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Sciences, College of Arts and Sciences, Ohio University, Athens, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oaks</LastName><ForeName>Rosemary J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Program in Biological Sciences, Honors Tutorial College, Ohio University, Athens, Ohio, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences and Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thuma</LastName><ForeName>Jean R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Specialty Medicine, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Diabetes Institute, Ohio University, Athens, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malgor</LastName><ForeName>Ramiro</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Interdisciplinary Program in Molecular and Cellular Biology, Ohio University, Athens, Ohio, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences and Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Diabetes Institute, Ohio University, Athens, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwartz</LastName><ForeName>Frank L</ForeName><Initials>FL</Initials><AffiliationInfo><Affiliation>Department of Specialty Medicine, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Diabetes Institute, Ohio University, Athens, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coschigano</LastName><ForeName>Karen T</ForeName><Initials>KT</Initials><AffiliationInfo><Affiliation>Interdisciplinary Program in Molecular and Cellular Biology, Ohio University, Athens, Ohio, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences and Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Diabetes Institute, Ohio University, Athens, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCall</LastName><ForeName>Kelly D</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>Interdisciplinary Program in Molecular and Cellular Biology, Ohio University, Athens, Ohio, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Sciences, College of Arts and Sciences, Ohio University, Athens, Ohio, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences and Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Specialty Medicine, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Diabetes Institute, Ohio University, Athens, Ohio, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U2C DK093000</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Viral Immunol</MedlineTA><NlmUniqueID>8801552</NlmUniqueID><ISSNLinking>0882-8245</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051192">Receptors, Pattern Recognition</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="N">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003921" MajorTopicYN="N">Diabetes Mellitus, Experimental</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="Y">Enterovirus B, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000076662" MajorTopicYN="N">Host Microbial Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D052177" MajorTopicYN="N">Kidney Diseases, Cystic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016688" MajorTopicYN="N">Mice, Inbred NOD</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051192" MajorTopicYN="N">Receptors, Pattern Recognition</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">NOD</Keyword><Keyword MajorTopicYN="N">TLR3</Keyword><Keyword MajorTopicYN="N">coxsackievirus</Keyword><Keyword MajorTopicYN="N">kidney</Keyword></KeywordList><CoiStatement>No competing financial interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32352894</ArticleId><ArticleId IdType="pmc">PMC7478222</ArticleId><ArticleId IdType="doi">10.1089/vim.2019.0188</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alexopoulou L, Holt AC, Medzhitov R, et al. . Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001;413:732&#x2013;738</Citation><ArticleIdList><ArticleId IdType="pubmed">11607032</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen CL, Jensen JL, and Orntoft F. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 2004;64:5245&#x2013;5250</Citation><ArticleIdList><ArticleId IdType="pubmed">15289330</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreoletti L, Hober D, Hober-Vandenberghe C, et al. . Detection of coxsackie B virus RNA sequences in whole blood samples from adult patients at the onset of type 1 diabetes mellitus. Med Virol 1998;52:121&#x2013;127</Citation><ArticleIdList><ArticleId IdType="pubmed">9179756</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronson MD, and Phillips CA. Coxsackievirus B5 infections in acute oliguric renal failure. J Infect Dis 1975;132:303&#x2013;306</Citation><ArticleIdList><ArticleId IdType="pubmed">1159332</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkinson MA, and Gianani R. The pancreas in human type 1 diabetes: providing new answers to age-old questions. Curr Opin Endorcrinol Diabetes Obes 2009;16:279&#x2013;285</Citation><ArticleIdList><ArticleId IdType="pubmed">19502978</ArticleId></ArticleIdList></Reference><Reference><Citation>Banatvala JE, Bryant J, Schernthaner G, et al. . Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia. Lancet Lond Engl 1985;1409&#x2013;1412</Citation><ArticleIdList><ArticleId IdType="pubmed">2861361</ArticleId></ArticleIdList></Reference><Reference><Citation>Baron S, Fons M, and Albrecht T. Viral pathogenesis. In Baron S, ed. Medical Microbiology. Galveston, TX: University of Texas Medical Branch at Galveston, ch. 45, 1996;3&#x2013;4</Citation><ArticleIdList><ArticleId IdType="pubmed">21413306</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayatpour M, Zbitnew A, Dempster G, et al. . Role of coxsackievirus B4 in the pathogenesis of acute glomerulonephritis. Can Med Assoc J 1973;109:873&#x2013;875</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1946988</ArticleId><ArticleId IdType="pubmed">4750301</ArticleId></ArticleIdList></Reference><Reference><Citation>Burch GE. Progressive coxsackie viral pancarditis and nephritis. Ann Intern Med 1969;71:963.</Citation><ArticleIdList><ArticleId IdType="pubmed">4902582</ArticleId></ArticleIdList></Reference><Reference><Citation>Conaldi PG, Biancone L, Bottelli A, et al. . Distinct pathogenic effects of group B coxsackieviruses on human glomerular and tubular kidney cells. J Virol 1997;71:9180&#x2013;9187</Citation><ArticleIdList><ArticleId IdType="pmc">PMC230220</ArticleId><ArticleId IdType="pubmed">9371576</ArticleId></ArticleIdList></Reference><Reference><Citation>Coschigano KT, Wetzel AN, Obichere N, et al. . Identification of differentially expressed genes in the kidneys of growth hormone transgenic mice. Growth Horm IGF Res 2010;20:345&#x2013;355</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2948615</ArticleId><ArticleId IdType="pubmed">20655258</ArticleId></ArticleIdList></Reference><Reference><Citation>Drescher KM, Kono K, Bopegamage S, et al. . Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection. Virology 2004;329:381&#x2013;394</Citation><ArticleIdList><ArticleId IdType="pubmed">15518817</ArticleId></ArticleIdList></Reference><Reference><Citation>Faulhaber JR, and Nelson PJ. Virus-induced cellular immune mechanisms of injury to the kidney. Clin J Am Soc Nephrol 2007;2:S2&#x2013;S5</Citation><ArticleIdList><ArticleId IdType="pubmed">17699506</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimoto M, Maezawa Y, Yokote K, et al. . Mice lacking smad3 are protected against streptozotocin-induced diabetic glomerulopathy. Biochem Biophys Res Commun 2003;305:1002&#x2013;1007</Citation><ArticleIdList><ArticleId IdType="pubmed">12767930</ArticleId></ArticleIdList></Reference><Reference><Citation>Gale EAM. The rise of childhood type 1 diabetes in the 20th century. Diabetes 2002;51:3353&#x2013;3361</Citation><ArticleIdList><ArticleId IdType="pubmed">12453886</ArticleId></ArticleIdList></Reference><Reference><Citation>Glassock RJ. Immune complex-induced glomerular injury in viral diseases: an overview. Kidney Int Suppl 1991;35:S5&#x2013;S7</Citation><ArticleIdList><ArticleId IdType="pubmed">1837573</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellemans J, Mortier G, De Paepe A, et al. . qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 2007;8:R19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1852402</ArticleId><ArticleId IdType="pubmed">17291332</ArticleId></ArticleIdList></Reference><Reference><Citation>Horwitz MS, Bradley LM, Harbertson J, et al. . Diabetes induced by coxsackie virus: initation by bystander damage and not molecular mimicry. Nat Med 1998;4:781&#x2013;785</Citation><ArticleIdList><ArticleId IdType="pubmed">9662368</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyoty H, Hiltunen M, Knip M, et al. . A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood diabetes in finland (DiMe) study group. Diabetes 1995;44:652&#x2013;657</Citation><ArticleIdList><ArticleId IdType="pubmed">7789630</ArticleId></ArticleIdList></Reference><Reference><Citation>Isome M, Yoshida K, Suzuki S, et al. . Experimental glomerulonephritis following successive inoculation of five different serotypes of group B coxsackieviruses in mice. Nephron 1997;77:93&#x2013;99</Citation><ArticleIdList><ArticleId IdType="pubmed">9380244</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen MM. Viruses and kidney disease. Am J Med 1967;43:897&#x2013;911</Citation><ArticleIdList><ArticleId IdType="pubmed">4964762</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamiyama S. Experimental glomerulonephritis induced by Coxsackie B4 virus in mice-glomerular changes associated with intermittent viral inoculations. Nihon Jinzo Gakkai Shi 1990;32:939&#x2013;948</Citation><ArticleIdList><ArticleId IdType="pubmed">2175817</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaprio J, Tuomilehto J, Koskenvuo M, et al. . Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 1992;35:1060&#x2013;1067</Citation><ArticleIdList><ArticleId IdType="pubmed">1473616</ArticleId></ArticleIdList></Reference><Reference><Citation>Lefever S, Vandesompele J, Speleman F, et al. . RTPrimerDB: the portal for real-time PCR primers and probes. Nucleic Acids Res 2009;37:D942&#x2013;D945</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2686610</ArticleId><ArticleId IdType="pubmed">18948285</ArticleId></ArticleIdList></Reference><Reference><Citation>McCall KD, Schmerr MJ, Thuma JR, et al. . Phenylmethimazole suppresses dsRNA-induced cytotoxicity and inflammatory cytokines in murine pancreatic beta cells and blocks viral acceleration of type 1 diabetes in NOD mice. Endocrinology 2013;18:3841&#x2013;3858</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6269916</ArticleId><ArticleId IdType="pubmed">23535518</ArticleId></ArticleIdList></Reference><Reference><Citation>McCall KD, Thuma JR, Courreges MC, et al. . Toll-like receptor 3 is critical for coxsackievirus B4-induced type 1 diabetes in female NOD mice. Endocrinology 2015;156:453&#x2013;461</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4298321</ArticleId><ArticleId IdType="pubmed">25422874</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasch A, and Frey FJ. Coxsackie B viruses and the kidney&#x2014;a neglected topic. Nephrol Dial Transplant 2006;21:1184&#x2013;1187</Citation><ArticleIdList><ArticleId IdType="pubmed">16490748</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad N, and Patel MR. Infection-induced kidney diseases. Front Med (Lausanne) 2018;5:327.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6282040</ArticleId><ArticleId IdType="pubmed">30555828</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2014</Citation></Reference><Reference><Citation>Rewers M, and Zimmet P. The rising tide of childhood type 1 diabetes&#x2014;what is the elusive environmental trigger? Lancet 2004:364:17368-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15530607</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012;9:671&#x2013;675</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5554542</ArticleId><ArticleId IdType="pubmed">22930834</ArticleId></ArticleIdList></Reference><Reference><Citation>Serreze DV, Chapman HD, Varnum DS, et al. . Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent. J Immunol 1997;158:3978&#x2013;3986</Citation><ArticleIdList><ArticleId IdType="pubmed">9103469</ArticleId></ArticleIdList></Reference><Reference><Citation>Serreze DV, Ottendorfer EW, Ellis TM, et al. . Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes 2000;49:708&#x2013;711</Citation><ArticleIdList><ArticleId IdType="pubmed">10905477</ArticleId></ArticleIdList></Reference><Reference><Citation>Serreze DV, Wasserfall C, Ottendorfer EW, et al. . Diabetes acceleration or prevention by a coxsackievirus B4 infection: critical requirements for both interleukin-4 and gamma interferon. J Virol 2005;79:1045&#x2013;1052</Citation><ArticleIdList><ArticleId IdType="pmc">PMC538592</ArticleId><ArticleId IdType="pubmed">15613333</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh HK, and Nickeleit V. Kidney disease caused by viral infections. Curr Diagn Pathol 2004;10:11&#x2013;21</Citation></Reference><Reference><Citation>Sun SC. The noncanonical NF-&#x3ba;B pathway. Immunol Rev 2012;246:125&#x2013;140</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3313452</ArticleId><ArticleId IdType="pubmed">22435551</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracy S, Drescher KM, Chapman NM, et al. . Toward testing the hypothesis that group B coxsackievirus (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB marketdly lowers diabetes incidence. J Virol 2002;76:12097&#x2013;12111</Citation><ArticleIdList><ArticleId IdType="pmc">PMC136885</ArticleId><ArticleId IdType="pubmed">12414951</ArticleId></ArticleIdList></Reference><Reference><Citation>USRDS. 2017. USRDS annual data report: epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2017</Citation></Reference><Reference><Citation>Vandesompele J, De Preter K, Pattyn F, et al. . Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002;3:RESEARCH0034.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC126239</ArticleId><ArticleId IdType="pubmed">12184808</ArticleId></ArticleIdList></Reference><Reference><Citation>Viruses and renal disease. JAMA 1968;204:539</Citation><ArticleIdList><ArticleId IdType="pubmed">4869063</ArticleId></ArticleIdList></Reference><Reference><Citation>vonHerrath MG, Fujinami RS, and Whitton JL. Microorganisms and autoimmunity: making the barren field fertile? Nat Rev Microbiol 2003;1:151&#x2013;157</Citation><ArticleIdList><ArticleId IdType="pubmed">15035044</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb SR, Loria RM, Madge GE, et al. . Susceptibility of mice to group B coxsackie virus is influenced by the diabetic gene. J Exp Med 1976;143:1239&#x2013;1248</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2190198</ArticleId><ArticleId IdType="pubmed">772154</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong FS, Hu C, Zhang L, et al. . The role of Toll-like receptors 3 and 9 in the development of autoimmune diabetes in NOD mice. Ann N Y Acad Sci 2008;1150:146&#x2013;148</Citation><ArticleIdList><ArticleId IdType="pubmed">19120284</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao X, Ma B, Dong B, et al. . Cellular and humoral immune responses in the early stages of diabetic nephropathy in NOD mice. J Autoimmun 2009;32:85&#x2013;93</Citation><ArticleIdList><ArticleId IdType="pubmed">19200691</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye J, Coulouris G, Zaretskaya I, et al. . Primer-BLASt: A tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics 2012;13:134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3412702</ArticleId><ArticleId IdType="pubmed">22708584</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon JW, and Jun HS. Viruses cause type 1 diabetes in animals. Ann. N. Y. Acad. Sci 2006;1097:138&#x2013;146</Citation><ArticleIdList><ArticleId IdType="pubmed">17130545</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida K, Suzuki J, Suzuki S, et al. . Experimental IgA nephropathy induced by coxsackie B4 virus in mice. Am J Nephrol 1997;17:81&#x2013;88</Citation><ArticleIdList><ArticleId IdType="pubmed">9057958</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou HT, Wang B, and Che XY. Nephrotic syndrome in hand, foot and mouth disease caused by coxsackievirus A16: a case report. Int J Infect Dis 2014;28:1&#x2013;2</Citation><ArticleIdList><ArticleId IdType="pubmed">25124453</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>